Matches in Wikidata for { <http://www.wikidata.org/entity/Q91558117> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q91558117 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q91558117 description "scientific article published on 03 April 2020" @default.
- Q91558117 description "wetenschappelijk artikel" @default.
- Q91558117 description "наукова стаття, опублікована 3 квітня 2020" @default.
- Q91558117 name "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 name "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 type Item @default.
- Q91558117 label "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 label "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 prefLabel "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 prefLabel "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 P1433 Q91558117-734C1B45-47F8-46E5-8E72-F47205EA6FF9 @default.
- Q91558117 P1476 Q91558117-C8C21FC9-49E1-4FFB-897A-9F57F9394229 @default.
- Q91558117 P2093 Q91558117-07D95B72-D3E5-4866-B6C9-7F99586FA423 @default.
- Q91558117 P2093 Q91558117-26546DA5-8298-4CE7-BC0D-B16C26BF636C @default.
- Q91558117 P2093 Q91558117-30EDD289-EC14-4B6C-80A7-74E5C19024AA @default.
- Q91558117 P2093 Q91558117-3E67614E-BF5D-4630-B1A4-68F9F19680B5 @default.
- Q91558117 P2093 Q91558117-590CE1FD-CF69-4A21-8F04-66FF002890B0 @default.
- Q91558117 P2093 Q91558117-5B43ADDE-AD41-4146-BE55-7556E46E0414 @default.
- Q91558117 P2093 Q91558117-8BC9FF2F-A1AA-4F51-B1B6-C9B9787E8D31 @default.
- Q91558117 P2093 Q91558117-A60958B5-EC86-40AD-9536-12A4FF8CED3D @default.
- Q91558117 P31 Q91558117-D97B7C70-2C8B-42C3-B38C-0A619E2B2242 @default.
- Q91558117 P356 Q91558117-BAD468BC-A798-4555-9F2D-65350ECFC8B2 @default.
- Q91558117 P50 Q91558117-1DB6FDE3-1CA3-4C83-81D2-34F78C77936D @default.
- Q91558117 P50 Q91558117-7BDD6182-CF4B-4BFA-9FB1-4AE3969BC20B @default.
- Q91558117 P50 Q91558117-92030994-0F48-4533-AB4C-3DB889420AE8 @default.
- Q91558117 P50 Q91558117-C36153AA-E0A2-41E9-8269-B0DA5D1573DE @default.
- Q91558117 P50 Q91558117-CC295C92-C23E-4645-ADFE-580647BA632C @default.
- Q91558117 P50 Q91558117-F50803F0-DD5D-4ECF-A62B-CBC45FF468CC @default.
- Q91558117 P577 Q91558117-019FB5A5-DEF5-45D1-890C-D36A378B4820 @default.
- Q91558117 P698 Q91558117-6C51E051-6F7A-4851-9A67-38FE44FCF684 @default.
- Q91558117 P356 S11060-020-03470-3 @default.
- Q91558117 P698 32246395 @default.
- Q91558117 P1433 Q15752119 @default.
- Q91558117 P1476 "GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma" @default.
- Q91558117 P2093 "Bernhard H Rauch" @default.
- Q91558117 P2093 "Fabian Wilken" @default.
- Q91558117 P2093 "Henry W S Schroeder" @default.
- Q91558117 P2093 "Isabel Wagner" @default.
- Q91558117 P2093 "Joerg Baldauf" @default.
- Q91558117 P2093 "Martin Weidemeier" @default.
- Q91558117 P2093 "Sandra Bien-Moeller" @default.
- Q91558117 P2093 "Steffen K Fleck" @default.
- Q91558117 P31 Q13442814 @default.
- Q91558117 P356 "10.1007/S11060-020-03470-3" @default.
- Q91558117 P50 Q23926576 @default.
- Q91558117 P50 Q58658162 @default.
- Q91558117 P50 Q58658164 @default.
- Q91558117 P50 Q91333545 @default.
- Q91558117 P50 Q91558107 @default.
- Q91558117 P50 Q91558113 @default.
- Q91558117 P577 "2020-04-03T00:00:00Z" @default.
- Q91558117 P698 "32246395" @default.